Skip to main content
. 2020 Jun;20(2):549–559. doi: 10.4314/ahs.v20i2.2

Table 2.

Percentage drug resistance reported for protease inhibitors (PIs)

Resistance level
(%)
Low Intermediate High Susceptible
Atazanavir/r 14.3 28.6 57.1 0
Darunavir/r 19.1 33.3 0 47.6
Fosamprenavir/r 19.1 14.3 66.7 0
Indinavir/r 4.8 14.3 80.9 0
Lopinavir/r 14.3 9.5 76.2 0
Nelfinavir/r 0 14.3 85.7 0
Saquinavir/r 19.1 57.1 19.1 4.8
Tipranavir/r 33.3 38.1 4.8 23.8